Abby Ganske is a Iowa City, Iowa based nurse practitioner. Active license number of Abby Ganske is A182581 for Pediatrics in Iowa. Her current practice location is 200 Hawkins Dr, Iowa City. Patients can reach her at 319-356-3705 or can fax her at 319-384-6295. Abby Ganske is FNP and her NPI number (Unique professional ID assigned by NPPES) is 1295347664. Abby Ganske has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Abby Ganske speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1295347664
NPI Enumeration Date:
18 Aug, 2020
NPI Last Update On:
18 Feb, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Abby Ganske are as mentioned below.
License Number
Specialization
State
Status
A182581
Pediatrics
Iowa
Primary
245216
Registered Nurse
Arizona
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Abby Ganske 200 Hawkins Dr, Iowa City, Iowa
Zip:
52242-1009
Phone Number:
319-356-3705
Fax Number:
319-384-6295
Patients can reach Abby Ganske at 200 Hawkins Dr, Iowa City, Iowa or can call to book an appointment on 319-356-3705.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 10 March, 2025.